95 related articles for article (PubMed ID: 28929537)
21. Current management of non-squamous carcinoma of the cervix.
Gallup DG; Stock RJ; Talledo OE
Oncology (Williston Park); 1989 May; 3(5):95-102; discussion 104, 106. PubMed ID: 2577885
[TBL] [Abstract][Full Text] [Related]
22. A comparison of prognoses of pathologic stage Ib adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Nakanishi T; Ishikawa H; Suzuki Y; Inoue T; Nakamura S; Kuzuya K
Gynecol Oncol; 2000 Nov; 79(2):289-93. PubMed ID: 11063659
[TBL] [Abstract][Full Text] [Related]
23. Patterns of spread in node-positive cervical cancer: the relationship between local control and distant metastases.
Stock RG; Chen AS; Karasek K
Cancer J Sci Am; 1996; 2(5):256-62. PubMed ID: 9166542
[TBL] [Abstract][Full Text] [Related]
24. Clinical evaluation of neoadjuvant chemotherapy followed by radical surgery in the management of stage IB2-IIB cervical cancer.
Gong L; Lou JY; Wang P; Zhang JW; Liu H; Peng ZL
Int J Gynaecol Obstet; 2012 Apr; 117(1):23-6. PubMed ID: 22265255
[TBL] [Abstract][Full Text] [Related]
25. Therapy and survival of early invasive carcinoma of the cervix uteri with metastases to the pelvic nodes.
Jobson VW; Girtanner RE; Averette HE
Surg Gynecol Obstet; 1980 Jul; 151(1):27-9. PubMed ID: 7384981
[No Abstract] [Full Text] [Related]
26. Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.
Kornovski Y; Gorchev G
J BUON; 2006; 11(3):291-7. PubMed ID: 17309152
[TBL] [Abstract][Full Text] [Related]
27. Survival of women with Mullerian adenosarcoma: A National Cancer Data Base study.
Seagle BL; Kanis M; Strohl AE; Shahabi S
Gynecol Oncol; 2016 Dec; 143(3):636-641. PubMed ID: 27771166
[TBL] [Abstract][Full Text] [Related]
28. Concurrent chemoradiotherapy with or without surgery for patients with resectable esophageal cancer: An analysis of the National Cancer Data Base.
Naik KB; Liu Y; Goodman M; Gillespie TW; Pickens A; Force SD; Steuer CE; Owonikoko TK; Ramalingam SS; Higgins K; Beitler JJ; Shin DM; Willingham FF; El-Rayes B; Landry JC; Fernandez FG; Saba NF
Cancer; 2017 Sep; 123(18):3476-3485. PubMed ID: 28464264
[TBL] [Abstract][Full Text] [Related]
29. Exploring differences in survival from cancer among Indigenous and non-Indigenous Australians: implications for health service delivery and research.
Chong A; Roder D
Asian Pac J Cancer Prev; 2010; 11(4):953-61. PubMed ID: 21133607
[TBL] [Abstract][Full Text] [Related]
30. Impact of histological subtype on survival in patients with locally advanced cervical cancer that were treated with definitive radiotherapy: adenocarcinoma/adenosquamous carcinoma versus squamous cell carcinoma.
Yokoi E; Mabuchi S; Takahashi R; Matsumoto Y; Kuroda H; Kozasa K; Kimura T
J Gynecol Oncol; 2017 Mar; 28(2):e19. PubMed ID: 28028992
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
[TBL] [Abstract][Full Text] [Related]
32. Mortality trends for cervical squamous and adenocarcinoma in the United States. Relation to incidence and survival.
Sherman ME; Wang SS; Carreon J; Devesa SS
Cancer; 2005 Mar; 103(6):1258-64. PubMed ID: 15693030
[TBL] [Abstract][Full Text] [Related]
33. Survival after stage IA endometrial cancer; can follow-up be altered? A prospective nationwide Danish survey.
Lajer H; Elnegaard S; Christensen RD; Ortoft G; Schledermann DE; Mogensen O
Acta Obstet Gynecol Scand; 2012 Aug; 91(8):976-82. PubMed ID: 22548255
[TBL] [Abstract][Full Text] [Related]
34. (
Scher N; Castelli J; Depeursinge A; Bourhis J; Prior JO; Herrera FG; Ozsahin M
Cancer Radiother; 2018 May; 22(3):229-235. PubMed ID: 29650390
[TBL] [Abstract][Full Text] [Related]
35. Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.
Luo M; Shen D; Wang W; Xian J
Int J Clin Exp Pathol; 2015; 8(5):5542-8. PubMed ID: 26191262
[TBL] [Abstract][Full Text] [Related]
36. Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.
Bean LM; Ward KK; Plaxe SC; McHale MT
Am J Obstet Gynecol; 2017 Sep; 217(3):332.e1-332.e6. PubMed ID: 28522318
[TBL] [Abstract][Full Text] [Related]
37. Prognosis and clinicopathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy.
Irie T; Kigawa J; Minagawa Y; Itamochi H; Sato S; Akeshima R; Terakawa N
Eur J Surg Oncol; 2000 Aug; 26(5):464-7. PubMed ID: 11016467
[TBL] [Abstract][Full Text] [Related]
38. Treatment and survival from breast cancer: the experience of patients at South Australian teaching hospitals between 1977 and 2003.
Luke C; Gill G; Birrell S; Humeniuk V; Borg M; Karapetis C; Koczwara B; Olver I; Penniment M; Pittman K; Price T; Walsh D; Yeoh EK; Roder D
J Eval Clin Pract; 2007 Apr; 13(2):212-20. PubMed ID: 17378867
[TBL] [Abstract][Full Text] [Related]
39. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
40. A study of treatments and outcomes in elderly women with cervical cancer.
Shimamoto K; Saito T; Kitade S; Tomita Y; Nagayama R; Yamaguchi S; Ariyoshi K; Okadome M
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():174-179. PubMed ID: 29960201
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]